Guru Ownership Trend
Guru Analysis for Genmab A/S (GMAB)
Genmab A/S (GMAB), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q4 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $98.32 M.
Top institutional holders include Renaissance Technologies (RenTech) and Cliff Asness.
Institutional sentiment is currently Bullish. This is evidenced by a $20.94 M net inflow during the quarter.
Recent activity highlights Manning & Napier Group who opened a new position.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q4 2025)
Guru Consensus (Q4 2025)
FAQs for Genmab A/S (GMAB)
Major holders include Renaissance Technologies (RenTech) ($107.58 M), Cliff Asness ($2.53 M), Manning & Napier Group ($2,267). According to the latest reported data, 3 tracked investment managers collectively hold approximately 3.58 M shares.
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $20.94 M, with 3 managers increasing positions and 0 managers reducing holdings.
No tracked managers reduced or fully exited their positions in GMAB during the most recent reporting period.
Yes, 1 managers opened new positions in GMAB, and 2 increased their existing holdings. The total reported buy value was $20.94 M.